Drug Profile
Research programme: small molecule therapeutics - Taiho Pharmaceuticals/X-Chem
Latest Information Update: 28 Jan 2021
Price :
$50
*
At a glance
- Originator X-Chem
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Jan 2021 No recent reports of development identified for research development in Unspecified in Japan
- 20 Dec 2016 X-Chem and Taiho Pharmaceutical enter research collaboration and option agreement for development of small molecule therapeutics
- 20 Dec 2016 Early research in Undefined indication in Japan (unspecified route)